Advertisement
UK markets close in 6 hours 29 minutes
  • FTSE 100

    8,301.23
    +25.85 (+0.31%)
     
  • FTSE 250

    20,904.70
    +174.58 (+0.84%)
     
  • AIM

    807.64
    +1.85 (+0.23%)
     
  • GBP/EUR

    1.1716
    -0.0026 (-0.22%)
     
  • GBP/USD

    1.2705
    -0.0034 (-0.27%)
     
  • Bitcoin GBP

    54,427.81
    +1,125.40 (+2.11%)
     
  • CMC Crypto 200

    1,493.68
    +25.74 (+1.75%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.82 (+1.51%)
     
  • CRUDE OIL

    77.10
    +0.11 (+0.14%)
     
  • GOLD FUTURES

    2,346.10
    +0.30 (+0.01%)
     
  • NIKKEI 225

    38,923.03
    +435.13 (+1.13%)
     
  • HANG SENG

    18,403.04
    +323.43 (+1.79%)
     
  • DAX

    18,663.54
    +165.60 (+0.90%)
     
  • CAC 40

    8,036.67
    +43.80 (+0.55%)
     

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating

Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.